Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis
CONCLUSION: Careful monitoring of severe AEs in patients with T2DM may be necessary, especially for those related to thrombotic events and neurological dysfunctions after COVID-19 vaccination.PMID:36872064 | DOI:10.4093/dmj.2022.0129
Source: Diabetes and Metabolism Journal - Category: Endocrinology Authors: Hye Jun Kim Sang Jun Lee Soonok Sa Jung Ho Bae Gyuseon Song Chae Won Lee Ju Hee Kim Sung Ryul Shim Myunghee Hong Hyun Wook Han Source Type: research
More News: Bell's Palsy | Brain | Coronavirus | Covid Vaccine | COVID-19 | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Encephalitis | Endocrinology | Ischemic Stroke | Neurology | Pulmonary Thromboembolism | Stroke | Study | Thrombocytopenia | Thrombosis | Vaccines